Status:
COMPLETED
Study of Chemotherapy and Patient Health Outcomes for Nausea and Emesis (0000-041)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Chemotherapy Induced Nausea and Vomiting
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to assess whether timely feedback to providers on patient experiences with delayed chemotherapy induced nausea and vomiting (CINV) lead to differences in patient outcomes ...
Eligibility Criteria
Inclusion
- Highly or moderately emetogenic chemotherapy planned for at least 2 cycles
Exclusion
- Concurrent other anti-cancer therapy (e.g. radiation, hormone, etc.); vomiting during the 24 hours prior to first chemotherapy cycle; having a disease/condition or taking medication that may cause emesis
Key Trial Info
Start Date :
August 1 2004
Trial Type :
INTERVENTIONAL
End Date :
December 1 2005
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT00211601
Start Date
August 1 2004
End Date
December 1 2005
Last Update
May 1 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.